Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 14, 2024

SELL
$0.91 - $1.35 $712 - $1,057
-783 Closed
0 $0
Q3 2023

Aug 14, 2024

BUY
$1.07 - $1.6 $9 - $14
9 Added 1.16%
783 $948,000
Q2 2023

Aug 14, 2024

SELL
$0.99 - $2.04 $92 - $189
-93 Reduced 10.73%
774 $883,000
Q2 2022

Aug 14, 2024

SELL
$0.78 - $1.1 $13 - $18
-17 Reduced 1.92%
867 $674,000
Q1 2022

Aug 14, 2024

BUY
$0.82 - $1.1 $724 - $972
884 New
884 $765,000
Q3 2021

Aug 30, 2024

BUY
$1.45 - $1.84 $71 - $90
49 Added 6.08%
855 $1.31 Million
Q2 2021

Aug 30, 2024

BUY
$1.56 - $2.13 $1,257 - $1,716
806 New
806 $1.41 Million
Q2 2020

Aug 30, 2024

SELL
$2.58 - $7.39 $108 - $310
-42 Reduced 4.95%
806 $3.04 Million
Q1 2020

Aug 30, 2024

BUY
$2.55 - $10.86 $2,162 - $9,209
848 New
848 $2.97 Million

About FSD Pharma Inc.


  • Ticker HUGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 38,218,100
  • Market Cap $146M
  • Description
  • FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...
More about HUGE
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.